Blair Robertson

Vice President Late Stage Indications and Global Market Strategy - Rozimab Mission

Ucb
Blair Robertson is a skilled professional, that works in Ucb as a Vice President Late Stage Indications and Global Market Strategy - Rozimab Mission from 2019. Blair gained professional experience in more than 11 positions at different companies. Blair Robertson went to the Kellogg School of Management and was studying to 2008. West Concord, Massachusetts is the area, where this person was lastly known to be situated. This person's email address and phone number can be easily accessed through Connexy by request.
Name variants:
Blaire Robertson

Contact Information

Last Update
Jun 30, 2022
Email
bl**@baxalta.com, bl**@gmail.com, bl**@gmail.com
Location
West Concord, MA
Company
Ucb

Workplace

Vice President Late Stage Indications and Global Market Strategy - Rozimab Mission

Work History

Vice President Late Stage Indications and Global Market Strategy - Rozimab Mission

Ucb
Differentiating Experience Lead- Rozimab (Rozanolixizumab) Mission Head of Commercial Strategy. Leading a team to develop the best possible patient and HCP experience for Rozimab, including ...
from Feb 2019

Vice President and Head of Franchise Operations, Global Rare Diseases

Aug 2017 — Jan 2019

Senior Director; Global Dupilumab Marketing

Professional Marketing Lead for first biologic (IL4-IL13 inhibition) in Atopic Dermatitis
Jun 2016 — Aug 2017

Senior Director Global Marketing , Blood Disorders Franchise

Global Commercial Lead for the hematology rare disease VWD and Sickle Cell programs Leading Baxalta's recently approved global rVWF VONVENDI launch. Includes submission, and post approval...
Apr 2014 — Jun 2016

Chief Strategy Officer

Lead strategy, accounts, digital and clinical teams for rare disease advertising agency
Aug 2013 — Apr 2014

Chief Commercial Officer

Responsible for commercial and medical leadership for rare and orphan diseases including global marketing, communications, regulatory, distribution, sales, and medical affairs for all Cambro...
Jul 2011 — Jul 2013

Senior Director New Product Planning

Provide commercial evaluation and strategic fit of external assets for acquisition and/or alliance, and internal R&D programs, thus supporting the expansion HGT ‘s rare and orphan disease gr...
May 2009 — Jul 2011

Vice President and Head of Strategic Portfolio Management and Ventavis Marketing For Spec Therapeutics Business Unit

Managed strategic development of a $B multiple sclerosis, neurology, ophthalmology and autoimmune product portfolio and identifying new products for optimization of the specialized therapeut...
Jan 2007 — Apr 2009

Global Strategic Marketing Director

Managed the development and implementation for the global marketing campaign for the biologic Trasylol. Ensured country alignment in all major markets and regions with commercial and clinica...
Jan 2006 — Jan 2007

Us Primary Care Marketing Director

P&L responsibility for $250 MM Omnicef antibiotic. All commercial, life cycle, advocacy, budget and supply chain management for Brand. Report to GM of anti-infective marketing. Full control ...
Apr 2003 — Dec 2005

Deputy Director

Deputy Director, US Anti-infective Franchise. Developed US primary care marketing materials and marketing strategy. Commercial business development, marketing in-licensing team representat...
Apr 1998 — Mar 2003

Occupations

Executive
Vice President
Chief Executive

Skills

Pharmaceutical Industry
Commercialization
Global Marketing
Strategy
Biotechnology
Product Launch
Clinical Trials
Marketing Strategy
Medical Affairs
Competitive Analysis
Cross Functional Team Leadership
Clinical Development
Strategic Planning
Pharmaceutical Sales
Infectious Diseases
Biopharmaceuticals
Market Access
Oncology
Managed Care
Product Development
Cardiology
Lifesciences
Drug Development
Biologics
Sales Effectiveness
Medical Devices
Hematology
Dermatology
Sales Management
Diabetes
Hospital Sales
Gastroenterology
International Marketing
Medicine
Anti Infectives
Rare Diseases
Therapeutic Areas
Vaccines
Pharmaceuticals
Portfolio Management
Strategic Partnerships
Endocrinology
Orphan Diseases
Global Strategy
Leadership
Marketing
Business Development
Management
About